1. Wollett H. Questioning "mother hoad" as a model for womens lives and development. Paper presented at Womtn and psychology Conference, University of Leeds 1995.
2. Сметник В.П., Тумилович Л.Г. Неоперативная гинекология. М.: Медицинское информационное агентство, 2003.
3. Laml T, Schulz-Lobmeyr L, A Obruca Premature ovarian failure: etiology and prospects. Gynecol Endocrinol 2000; 14; 292–302.
4. Wheeler CA. Premature Ovarian Failure: treatment strategies. Journal of Reproduct Immunol Med J 1995; 76 (5): 130–1.
5. Davis SR. Premature Ovarian Failure. Мaturitas 1996; 23: 1–18.
6. Jones GS, de Morales-Ruehsen M. A new syndrome of amenorrhea in association with hypogonadotropism and apparently normal follicular apharatus. Am J Obstet Gynecol 1969; 104: 597.
7. O'Herlity C, Pepperell RJ, Evans JH. The significance of FSH Elevations in young women with disorders of ovulation. Brit Med J 1980; 281: 1447–50.
8. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992; 14: 103–15.
9. Epplen JT, Buitkamp J, Bocker T, Epplen C. Indirect gene diagnoses for complex (multifactorial) diseases. a review. Gene 1995; 159: 49–55.
10. Rebair RW, Conolly HV, Clinical ferlutes of young women with hypeigonadotropic amenorrhea. Fertil. Stetil 1990; 53: 804–10.
11. Vermeulen A. Environment, human reproduction, menopause and andropause. Environment Health Perspectives Supplements 1993; 101 (suppl 2): 91–100.
12. Samsioe G, Jansson I, Mellstrom P et al. The occurrence, nature out treatment of urinary in continence in a 70 year old population. Maturitus 1985; 7: 335–42.
13. Балан В.Е. Урогенитальные расстройства в климактерии (клиника, диагностика, заместительная гормонотерапия). Дис.… докт. мед. наук. М., 1998.
14. Van Der Rest M, Garrone R, Collagen Family of proteins. FASTB J 1991; 5: 2814–23.
15. Falkoner C, Malmstrom A, Ulmsten U, Barchan K et al. Changes in paraurethral connective trisue at mtnopause are counteracted by estrogen. Maturitas 1996; 24: 197–204.
16. Yamauchi M, Woodley D, Mechanic G, Aging and crosslinking of skin collagen. Biochem. Biophis. Res. Commun 1988; 152: 898–903.
17. Longcope C, Hunter R, Franz C. Steroid secretion by the postmenopausal ovary. Am J Obstet Gynecol 1980; 138: 564–8.
18. Burger HG, Dudley EC, Cui J et al. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000; 85: 2832–8.
19. Falsetti L, Scalchi S et al. Premature Ovarian Failure. Gynecol Endocrinol 1999 Jun 13(3), 189–95.
20. Beral V. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52, 705 women with breast cancer and 108411 women without breast cancer. Collaborative Group of Hormonal Factors in Breast Cancer. Lancet 1991; 349: 1047–59.
21. Рубченко Т.Н., Краснопольский В.И., Лукашенко С.Ю. Метаболические нарушения у женщин с хирургической менопаузой и их коррекция с помощью ЗГТ. Пробл. репрод. 1999; 5(3): 59–63.
22. Рябцева И.Т., Шаповалова К.А. Заместительная гормональная терапия при синдроме постовариоэктомии. Вест. Рос. ассоц. акуш.-гин. 2000; 2: 92–4.
23. Burger H, Davis S. Should women be treated with testosterone. Clinical Endocrinology 1998; 49: 159–60.
24. Kalantaridou SN. Premature ovarian failure – not jast a premature menopause. Материалы 11-го Всемирного конгресса во Флоренции. 2004; c.220.
25. Rudolf I, Zimmermann T, Kaminsky K et al. Changes in psychic and somatic well-being and cognitive capabilities of peri- and postmenopausal women after the use of hormone replacement drug containing estradiol valerate and levonorgestrel. Methods Find Exp Clin Pharmacol 2000;22(1):51–6.
26. Paoletti AM, Pilloni M, Orru M et al. Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel. Maturitas 2002; 42: 137–47.

Л.А.Марченко, Г.В.Тагиева, Л.М.Ильина

ГУ Научный центр акушерства, гинекологии и перинатологии 
(дир. – акад. РАМН В.И.Кулаков) РАМН, Москва